Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Partridge

Showing results (321-330 of 336) with videos related to

Pageof 34
Sort By:
The AAPS Journal|October 23, 2025
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 BiotherapeuticsSusan C Irvin, Samit Ganguly, Zhiqiang Wang, et al.
Skeletal Muscle|December 4, 2015
Elusive sources of variability of dystrophin rescue by exon skippingMaria Candida Vila, Margaret Benny Klimek, James S Novak, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2019
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trialsM Martín, S Loibl, T Hyslop, et al.
ACS Infectious Diseases|April 2, 2021
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: <i>Trichuris muris</i>, <i>Brugia malayi</i>, <i>Heligmosomoides polygyrus</i>, and <i>Schistosoma mansoni</i>Frederick A Partridge, Carole J R Bataille, Ruth Forman, et al.
The Journal of Pathology|March 19, 2019
Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx miceMaria C Vila, James S Novak, Margaret Benny Klimek, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Frontiers in Immunology|November 26, 2024
Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitisMohamed A Kamal, Matthew P Kosloski, Ching-Ha Lai, et al.
Journal of Intensive Care Medicine|November 7, 2023
Update on Management and Outcomes of Congenital Diaphragmatic HerniaK Taylor Wild, Holly L Hedrick, Anne M Ades, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2023
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upS Loibl, F André, T Bachelot, et al.
Pageof 34

Showing results (321-330 of 336) with videos related to

Sort By:
Pageof 34
The AAPS Journal|October 23, 2025
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 BiotherapeuticsSusan C Irvin, Samit Ganguly, Zhiqiang Wang, et al.
Skeletal Muscle|December 4, 2015
Elusive sources of variability of dystrophin rescue by exon skippingMaria Candida Vila, Margaret Benny Klimek, James S Novak, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2019
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trialsM Martín, S Loibl, T Hyslop, et al.
ACS Infectious Diseases|April 2, 2021
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: <i>Trichuris muris</i>, <i>Brugia malayi</i>, <i>Heligmosomoides polygyrus</i>, and <i>Schistosoma mansoni</i>Frederick A Partridge, Carole J R Bataille, Ruth Forman, et al.
The Journal of Pathology|March 19, 2019
Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx miceMaria C Vila, James S Novak, Margaret Benny Klimek, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Frontiers in Immunology|November 26, 2024
Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitisMohamed A Kamal, Matthew P Kosloski, Ching-Ha Lai, et al.
Journal of Intensive Care Medicine|November 7, 2023
Update on Management and Outcomes of Congenital Diaphragmatic HerniaK Taylor Wild, Holly L Hedrick, Anne M Ades, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2023
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upS Loibl, F André, T Bachelot, et al.
Pageof 34